Members Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.32M | Sell |
9,152
-215
| -2% | -$50.1K | 0.07% | 34 |
|
|
2026
Q1 | $2.29M | Sell |
9,367
-317
| -3% | -$73.8K | 0.08% | 29 |
|
|
2025
Q4 | $2M | Sell |
9,684
-390
| -4% | -$77.1K | 0.07% | 33 |
|
|
2025
Q3 | $1.87M | Sell |
10,074
-72
| -0.7% | -$12.3K | 0.06% | 32 |
|
|
2025
Q2 | $1.55M | Buy |
10,146
+1,488
| +17% | +$229K | 0.05% | 31 |
|
|
2025
Q1 | $1.44M | Buy |
8,658
+1,009
| +13% | +$158K | 0.05% | 31 |
|
|
2024
Q4 | $1.11M | Sell |
7,649
-187
| -2% | -$29K | 0.04% | 34 |
|
|
2024
Q3 | $1.27M | Sell |
7,836
-320
| -4% | -$51K | 0.04% | 31 |
|
|
2024
Q2 | $1.19M | Sell |
8,156
-161
| -2% | -$23.9K | 0.04% | 30 |
|
|
2024
Q1 | $1.32M | Sell |
8,317
-738
| -8% | -$117K | 0.04% | 26 |
|
|
2023
Q4 | $1.42M | Buy |
9,055
+21
| +0.2% | +$3.22K | 0.04% | 27 |
|
|
2023
Q3 | $1.42M | Hold |
9,034
| – | – | 0.04% | 28 |
|
|
2023
Q2 | $1.5M | Buy |
+9,034
| New | +$1.46M | 0.04% | 26 |
|
|
2022
Q4 | – | Sell |
-10,033
| Closed | -$1.64M | – | 76 |
|
|
2022
Q3 | $1.64M | Buy |
10,033
+126
| +1% | +$21.3K | 0.05% | 26 |
|
|
2022
Q2 | $1.76M | Sell |
9,907
-109
| -1% | -$19.4K | 0.06% | 26 |
|
|
2022
Q1 | $1.77M | Sell |
10,016
-592
| -6% | -$101K | 0.05% | 26 |
|
|
2021
Q4 | $1.81M | Buy |
10,608
+43
| +0.4% | +$7.04K | 0.05% | 26 |
|
|
2021
Q3 | $1.73M | Sell |
10,565
-64
| -0.6% | -$10.9K | 0.05% | 27 |
|
|
2021
Q2 | $1.75M | Sell |
10,629
-561
| -5% | -$92.9K | 0.06% | 27 |
|
|
2021
Q1 | $1.84M | Sell |
11,190
-6
| -0.1% | -$971 | 0.06% | 25 |
|
|
2020
Q4 | $1.76M | Buy |
11,196
+75
| +0.7% | +$11.1K | 0.06% | 26 |
|
|
2020
Q3 | $1.66M | Buy |
11,121
+698
| +7% | +$103K | 0.06% | 26 |
|
|
2020
Q2 | $1.47M | Buy |
+10,423
| New | +$1.52M | 0.06% | 29 |
|
|
2018
Q1 | $1.56M | Sell |
12,209
-890
| -7% | -$120K | 0.08% | 24 |
|
|
2017
Q4 | $1.83M | Buy |
13,099
+94
| +0.7% | +$13.1K | 0.1% | 21 |
|
|
2017
Q3 | $1.69M | Sell |
13,005
-66
| -0.5% | -$8.75K | 0.09% | 23 |
|
|
2017
Q2 | $1.73M | Buy |
13,071
+465
| +4% | +$59.3K | 0.1% | 21 |
|
|
2017
Q1 | $1.57M | Buy |
+12,606
| New | +$1.51M | 0.09% | 21 |
|
|
2016
Q3 | $1.57M | Buy |
13,270
+647
| +5% | +$78.5K | 0.1% | 22 |
|
|
2016
Q2 | $1.53M | Buy |
+12,623
| New | +$1.43M | 0.1% | 22 |
|
Other funds holding JNJ
AACR
Members Trust's JNJ Position: Q2 2026 in Review
Members Trust reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $50.1K and leaving 9,152 shares worth $2.32M. The position accounts for 0.07% of the portfolio, ranked #34.
Members Trust first reported a position in JNJ in Q2 2016 and has held it in 30 quarters since. 2,377 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Members Trust held 9,152 shares of Johnson & Johnson worth $2.32M as of Q2 2026.
- Members Trust sold 215 Johnson & Johnson shares in Q2 2026, an estimated $50.1K.
- Johnson & Johnson made up 0.07% of Members Trust's portfolio in Q2 2026, its #34 holding.
- Members Trust first reported a position in Johnson & Johnson in Q2 2016 and has held it in 30 quarters since.
- 2,377 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Members Trust's 13F filing for Q2 2026, filed 31 Jul 2026.